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Huntington's disease (HD) is causedbyan expandedCAG repeat in the huntingtin (HTT) gene, translating into an
elongated polyglutamine stretch. In addition to the neurotoxic mutant HTT protein, the mutant CAG repeat RNA
can exert toxic functions by trappingRNA-binding proteins.While fewexamples of proteins that aberrantly bind to
mutantHTTRNA and execute abnormal function in conjunction with the CAG repeat RNA have been described,
an unbiased approach to identify the interactome of mutantHTTRNA is missing. Here, we describe the analysis
of proteins that preferentially bind mutant HTT RNA using a mass spectrometry approach. We show that (I) the
majority of proteins captured by mutant HTT RNA belong to the spliceosome pathway, (II) expression of mutant
CAG repeat RNA inducesmis-splicing in aHD cell model, (III) overexpression of one of the splice factors trapped
by mutant HTT ameliorates the HD phenotype in a fly model and (VI) deregulated splicing occurs in human HD
brain. Our data suggest that deregulated splicing is a prominent mechanism of RNA-induced toxicity in HD.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Huntington's disease (HD) is caused by an expanded
CAG repeat motif in the huntingtin (HTT) gene,
translating into an elongated polyglutamine stretch in
the HTT protein. The pathological hallmark of HD is
aggregation of mutant HTT protein in patient brains [1].
Theseaggregatesareenriched in truncatedHTTprotein
species that are either generated by several proteases
or are a result of an aberrantly spliced exon1-transcript
and contain the polyglutamine stretch. Aggregate-prone
HTTproteinsplayacrucial role indiseasepathology, but
it is still unclear if the aggregates or folding intermediates
thereof represent the toxic species. Hence, it seems that
there are multiple mechanisms that each contributes a
little bit to toxicity [2–6].thors. Published by Elsevier Ltd. This is a
g/licenses/by-nc-nd/4.0/).A growing body of evidence argues that, in addition
to aggregate-prone proteins, the CAG repeat mRNA
itself contributes to neurotoxicity in CAG repeat
expansion disorders. Mechanistically, this likely in-
volves a gain-of-function at theRNA level [7,8].Mutant
HTT mRNA differs structurally from mRNA with
physiological CAG repeat lengths. While HTT tran-
scripts with non-disease causing numbers of repeats
exhibit either a very short or no CAG repeat hairpin
structure, in transcripts with disease-associated num-
bers of repeats, a CAG hairpin is present and
extended from a three-helix junction [9,10]. Aberrant
binding of proteins to these pathological RNA
structures may lead to aberrant functions of such
n open access article under the CC BY-NC-ND license
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1870 RNA-Induced Toxicity in Huntington's DiseaseRNA–protein complexes and may contribute to HD
pathogenesis [8,11].
Several examples of RNA-binding proteins that
are trapped by mutant HTT RNA have been
published to date. For example, the splicing factor
muscleblind 1 (MBNL1) co-localizes with the mutant
CAG repeat RNA, and as a result, the splicing
patterns of known MBNL1 target mRNAs are altered
in cell models and in HD patient cells [12]. Another
example is the endonuclease DICER that is an
essential component of the siRNA machinery. In cell
models as well as mouse models of HD, the mutant
CAG repeat RNA is cleaved by DICER into 21-nt-
long small CAG-repeated RNAs (sCAGs), which are
able to bind to CTG repeat containing genes through
the RNA interference machinery. Consequently, this
leads to deregulated expression of CTG repeat
containing genes [13]. Furthermore, proteins that are
trapped by mutant HTT RNA are translational
regulators that functionally induce translation of
mutant polyglutamine protein upon binding, like the
ubiquitin ligase MID1 [14]. These results suggest
that there will be more RNA-binding proteins
similarly recruited to mutant HTT mRNA and exert
abnormal function und thus could contribute to HD
pathology.
In this study, we investigated in an unbiased
experimental approach which proteins are captured
by HTT RNA in a CAG repeat length-dependent
manner. Our data show that the majority of proteins
that are sequestered bymutantHTTRNAbelong to the
spliceosome pathway. In line with this observation we
show that expression of mutant HTT induces mis-
splicing in anHDcellmodel. Furthermore,we show that
overexpression of one of the splice factors trapped by
mutant HTT rescues the toxic phenotype in an HD fly
model. Finally, we show that deregulated splicing
occurs in human HD brain. Our data suggest that
deregulated splicing is a major mechanism of RNA-
induced toxicity in HD.Mutant HTT RNA captures proteins that
belong to the splicing pathway
To identify proteins that are captured by mutant
HTT exon 1 (ex1) RNA and may be involved in RNA-
mediated neurotoxicity, we performed an RNA–
protein binding experiment using in vitro transcribed
HTTex1 RNAs containing wild-type or mutant CAG
repeats immobilized on magnetic beads as baits.
After incubation with cell extracts to allow RNA–
protein binding, beads were washed and RNA-
bound proteins were eluted and analyzed by
quantitative mass spectrometry. By this approach,
we identified 134 proteins that specifically bound to
HTTex1 RNA (Supplementary Fig. 1). Thirty-six of
these proteins bound in a length-dependent manner
with a higher affinity for RNAs harboring mutant CAGrepeats. The majority of these 36 proteins belong to
the splicing pathway (Fig. 1a/b, Supplementary Fig.
2, Supplementary Table 1). Splicing of nascent
precursor messenger RNA (pre-mRNA) molecules
to remove introns and link exons is carried out by the
spliceosome that consists of several proteins and
small nuclear RNAs. The major spliceosome com-
prises the small nuclear ribonucleoproteins
(snRNPs) U1, U2, U4, U5 and U6. Stepwise
sequential assembly of these snRNPs on the pre-
mRNA executes splicing reactions. Splicing starts
with U1 attaching to a specific sequence at the 5′
splice site of an exon. At the same time, U2
assembles at the branch site upstream of the 3′
splice site of the downstream exon, forming the
prespliceosome. Binding of the U5 and U4–U6
complexes to the prespliceosome results in forma-
tion of the precatalytic spliceosome. By unwinding of
the U4–U6 complexes, U4 and U1 are released from
the prespliceosomal complex. The 5′ splice site gets
cleaved, a looped structure, called lariat, is removed
and the two exons are covalently linked [15,16].
Interestingly, the 36 identified proteins that bind HTT
RNA in a CAG repeat length-dependent manner
include proteins of all snRNPs, U1, U2, U4, U5 and
U6. Among the identified proteins is SRSF6, a
known mutant HTT RNA interactor [17]. Further-
more, the identified proteins include PRPF8, a
splicing factor that is linked to polyglutamine-
mediated toxicity [18], as well as to the pathogenesis
of retinitis pigmentosa, a progressive neurodegen-
erative disease [19]. To validate the mass spec-
trometry data, we repeated the RNA–protein binding
experiment and detected all four splicing factors
tested, including the U5 subunit PRPF8, by Western
blot (Fig. 1c).Expression of mutant HTT induces
mis-splicing
Aberrant binding of the identified splicing factors
to mutant RNA may result in a loss of their
physiological functions. To test this, we generated
an SH-SY5Y cell line expressingHTT exon1 with 68
CAG repeats fused to GFP under an inducible
promoter (see Materials and Methods for details).
We then analyzed the splicing pattern of induced
versus uninduced cells on a splicing microarray.
Several mis-splicing events were detected upon
expression of mutant HTTex1 including retained
introns (20), alternative splice acceptor (22) and
splice donor (10) sites, and cassette exons (42) (Fig.
2a). Sequestration of the splice factors identified in
Fig. 1 by mutant HTT RNA is likely the reason for
these identified mis-splicing events. To validate this,
we focused on PRPF8 for further analysis. PRPF8 is
important for recognizing weak 5′ splice sites [20].
Supporting the idea that PRPF8 may be involved in
Fig. 1. Proteins that aberrantly bind mutantHTTex1 RNA are associated with splicing. (a) Schematic showing the splicing cycle. PRPF8, a U5-subunit, is indicated in
yellow. (b) HTT RNA-binding proteins were identified by RNA–protein pull-down followed by mass spectrometry. Mutant HTT RNA-interacting proteins (36 proteins
binding in a length-dependent manner) are significantly enriched for splicing factors (see also Supplementary Figs. 1, 2, 3, and Supplementary Table 1). A list of these
proteins is shown. (c) RNA–protein pull-downs of HTTex1 RNA with different repeat lengths analyzed on Western blot detecting the splice factors PRPF8, SF3B2,
SNRNP40 and SON. PRPF8 and SNRNP40 are components of the U5 snRNP, SF3B3 is a component of the U2 snRNP. SON probably acts by facilitating the
interaction between SRSF2 and the RNA polymerase II, which is required for formation of the earliest ATP-dependent splicing complex and for interactions of U1 and U2
snRNPs with pre-mRNA.
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Fig. 2. CREB1 is mis-spliced in an HD cell model and HD patients. (a) RNA of an SH-SY5Y cell model inducibly expressing
GFP-HTTex1(68CAG) was analyzed on a splicing microarray. Splicing patterns of uninduced controls and induced cells
expressing GFP-HTTex1(68CAG) were compared. The types and numbers of alternative splicing events with corresponding
splicing event score detected upon expression of GFP-HTTex1(68CAG) are shown. IR (intron retention), alt. 3′AC (alternative 3′
acceptor), alt. 5′D (alternative 5′ donor), CE (cassette exon). (b) Box plot of 5′ splice site strengths of retained introns compared to
non-retained introns, mean values ± SEM, *p b 0.05. (c) qRT-PCR validation of theCREB1 IR event in SH-SY5Y-GFP-HTTex1
(68CAG) cells described in panel a. Columns represent mean values ± SEM, *p b 0.05, n = 7 replicate experiments using
different passages of cells. p value is the result of a factorial ANOVA determining the effect of GFP-HTTex1(68CAG) expression
andcorrecting forCREB1exonexpressionanda confoundingeffect of theqPCRexperiments. (d)CREB1 IR eventmeasuredby
qRT-PCR after PRPF8 knockdown in uninduced SH-SY5Y-GFP-HTTex1(68CAG) cells, *p b 0.05, n = 4 replicate experiments
using different passages of cells. Columns represent mean values ± SEM; p value is the result of a factorial ANOVA determining
the knockdown effect and correcting forCREB1 exon expression and a confounding effect of the qPCRexperiments. In addition,
a Western blot controlling knockdown efficiency is shown.
1872 RNA-Induced Toxicity in Huntington's Diseasethe observed intron retention (IR) events that occur
upon mutantHTT expression, an in silico analysis of
splice site strengths showed that retained introns
had significantly weaker 5′ splice sites than properly
spliced introns (Fig. 2b).PRPF8 regulates splicing of CREB1
Prompted by the above-mentioned experiments
showing that splice factors including PRPF8 get
trapped by mutant HTT RNA and that expression of
mutant HTT RNA induces mis-splicing, we wanted
to validate that depletion of PRPF8 indeed induces
intron retention. Since out of the identified IR-RNAs
CREB1 has been previously linked to HD [21–24],
we focused on CREB1 for further analysis. First, we
validated the intron retention event in CREB1 after
expression of mutant HTTex1 RNA by quantitative
(q)RT-PCR (Fig. 2c). Second, to test if depletion of
PRPF8 indeed leads to mis-splicing of CREB1, we
performed a PRPF8 knock down experiment (Fig.
2d). As expected, depletion of PRPF8 resulted in
increased intron retention in the CREB1 transcript.
These data support the idea that capturing of
PRPF8 by mutant HTT RNA, and thus, its removalfrom its endogenous targets like CREB1 RNA
results in their missplicing.
Overexpression of PrP8 rescues the HD
phenotype
The above-mentioned experiments demonstrate
that splice factors including PRPF8 get trapped by
mutant HTT RNA, suggesting that they are thereby
functionally impaired leading to mis-splicing. This
deregulated splicing may be a molecular mechanism
underlying toxicity of mutant CAG repeat RNA. Thus,
overexpression of splice factors like PRPF8 should
ameliorate the HD phenotype. To test this hypothesis,
we used an established Drosophilamodel for HD that
expresses mutant human HTTex1 with 97 CAG
repeats under the control of the eye-specific GMR-
Gal4 driver, inducing loss of pigment cells [25].
Strikingly, co-expression of the PRPF8 homolog
Prp8 improved the eye phenotype, supporting
our finding that mis-splicing is amolecular mechanism
underlying toxicity of mutant CAG repeat RNA
(Fig. 3a, b). Of note, we suppose that co-expression
of further splicing factors would further suppress HTT
polyQ toxicity in the fly eye.
Fig. 3. Missplicing is an HD disease mechanism. (a) Expression of HTTex1 (CAG97) leads to death of pigment cells
(red) and a rough eye phenotype in Drosophila. (b) Co-expression of Prp8 ameliorates HTTex1-induced toxicity and
partially suppresses degeneration, as shown by fewer white patches and a more even eye appearance. Pictured are eyes
of male flies, 5 days old, raised at 27 °C. Genotypes: (a) GMR-Gal4/+; UAS-HttEx1Q97/+ (b) GMR-Gal4/+; UAS-
HttEx1Q97/UAS-flag-Prp8. (c) CREB1 IR event measured by qRT-PCR in human cortical tissue from unaffected
individuals and HD patients. **p b 0.001, ncontrol = 6, nHD = 8; p value is the result of a factorial ANOVA determining the
genotype effect and correcting for CREB1 exon expression and a confounding effect of the qPCR experiments.
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Finally, to test if mis-splicing also occurs in human
HD brain, we detected IR in CREB1 transcripts by
qRT-PCR in human brain samples of HD patients and
controls. Strikingly,weobserved a significant increase
in CREB1 intron retention in brain tissue of HD
patients (Fig. 3c).
To conclude, we present here an unbiased experi-
mental approach to identify proteins that are captured
by mutantHTTex1 RNA. The majority of these proteins
are splicing factors and their capturing results in
deregulated splicing of several RNAs including
CREB1. Our findings corroborate previously shown
deregulated CREB1 function in neurodegenerative
phenotypes and HD [21–24]. In addition, this recruit-
ment of splicing factors supports the previous observa-
tion that mutant HTT RNA sequesters splicing factors
such as SRSF6 (also identified here), which induces
missplicing of HTT transcript itself [17,26]. Our findings
are substantiated by a recent study describing exten-
sive mis-splicing in HD brains [27]. Our results
encourage further development of RNA-targeting strat-
egies to inhibit aberrant RNA–protein interactions and
thus stop mechanisms of RNA-induced toxicity in HD.
Materials and Methods
RNA pull-down
HTT exon 1 with varying CAG-repeat lengths was
PCR amplified using GoTaq® Green Master Mix(Promega). The forward primer contains the T7 phage
promotor sequence to facilitate in vitroRNA synthesis
by T7 RNA polymerase. The purified PCR product
was subjected to in vitro transcription using the T7
RiboMAX™ Express Large Scale RNA Production
System (Promega) with addition 0.5 mM biotin-UTP
(Thermo Fisher Scientific, AM8450). BiotinylatedRNA
was purified and folded in RNA structure buffer
[10 mM Tris (pH 7), 100 mM KCl, 10 mM MgCl2] by
incubation at 72 °C, 10 min, followed by cooling to
room temperature. Forty microliters of Dynabeads®
M-280 Streptavidin (Thermo Fisher Scientific) per
sample was incubated with 40 pmol of biotinylated
RNA in TKM buffer [20 mM Tris, 100 mM KCl, 5 mM
MgCl2, 1 mM DTT, 1% NP40, complete protease
inhibitor (Sigma-Aldrich), RiboLock RNase Inhibitor
(Thermo Fisher Scientific)] for 30 min at room
temperature. As a control, beads were coated with a
mix of dNTPs and bUTPs. The coated beads were
washed twice with TKM buffer. For protein lysates,
four 150-cm2 flasks of almost confluent SH-SY5Y
cells were harvested and pooled. The cell pellet was
lysed in 1 ml TKM buffer, homogenized using
Precellys®24Homogenizer (Peqlab), and centrifuged
for 10 min at 12,000g and 4 °C. One milligram of
protein lysate was added to the RNA coatedmagnetic
beads at a final volume of 400 μl TKM buffer. The
samples were incubated overnight at 4 °C. The beads
were washed three times, and beads were resus-
pended in 20 μl 1× SDS-PAGE sample buffer [50 mM
Tris–Cl (pH 6.8), 100 mM DTT, 2% SDS, 0.1%
bromophenol blue, 10% glycerol]. After incubation at
95 °C for 10 min, the eluted proteins were processed
1874 RNA-Induced Toxicity in Huntington's Diseasefor either Western blot or mass spectrometry analysis.
For mass spectrometry analysis, the experiment was
repeated five times on different days using different
preparations of RNA and cell lysates.
Mass spectrometry and data analysis
The eluted proteins were concentrated into one
band on an SDS-PAGE gel. The band was excised,
and the proteins were processed using an automated
sample preparation setup [28]. The generated pep-
tides were purified on StageTips [29]. The samples
were measured on a Q-Exactive mass spectrometer
(Thermo-Fisher) coupled to a Proxeon nano-LC
system (Thermo-Fisher) in data-dependent acquisi-
tion mode, selecting the top 10 peaks for HCD
fragmentation. A 1-h gradient (solvent A: 5% aceto-
nitrile, 0.1% formic acid; solvent B: 80% acetonitrile,
0.1% formic acid) was applied for the samples using
an in-house prepared nano-LC column (0.075 mm ×
150 mm, 3 μm Reprosil C18; Dr. Maisch GmbH). A
volume of 2 μl sample was injected, and the peptides
were eluted with 3 h gradients of 5% to 75% solvent B
at flow rates of 0.25 μl/min. MS acquisition was
performed at a resolution of 70,000 in the scan
range from 300 to 1700m/z. The normalized collision
energy was set to 26 eV. The mass window for
precursor ion selection was set to 2.0m/z. The
recorded spectra were analyzed using the MaxQuant
software package (Version 1.3.0.5) [30] by matching
the data to the Uniprot human database (downloaded
on 06.05.2012) with a false discovery rate of 1%.
Proteomic data analysis was performed using the
Perseus computational platform [31] (version
1.5.0.0) and R [32] (version 3.3). The results in
ProteinGroups.txt were filtered by removing all
entries corresponding to “Reverse,” “Contaminant”
or “Only identified by site.” Next, the protein LFQ
intensity values were log2 transformed and filtered
for at least four valid values in at least one group (C,
H20, H51 or H72). The missing values were imputed
from a normal distribution with a width of 0.3 and a
down shift of 1.8. Proteins, binding in a length-
dependent manner, were identified with limma [33]
(version 3.30.13) using a two-pass approach. First,
proteins that were significantly enriched by the CAG
repeats were identified using a contrast that com-
pares the average LFQ protein intensity across the
CAG repeats against the control. Second, the subset
of significantly enriched proteins (adjusted p value
b0.01) was analyzed using a three-way, pairwise
comparison of the difference in LFQ intensity
between a CAG repeat and the control. The p values
of the three comparisons were corrected for multiple
testing using limma's decide Tests function; the
method argument was set to “global,” and the adjust
method argument was set to “BH.” The proteins
showing positive, significant difference in at least
one comparison while not showing a negative,significant difference in any of the comparisons
were designated as binding in a length-dependent
manner.
For Gene Ontology Analysis of proteins, binding
CAG length-dependently ToppGene Suite was used
[34]. Proteins annotated with terms associated with
splicing were manually mapped to the specific
spliceosomal complexes [35].
Generation of stable cell line
To generate cell lines expressing Q68-GFP upon
tetracyclin induction, we used the Lenti-X Tet-On
3G Inducible Expression System (Clontech Labo-
ratories). HTT exon1 with 68 CAG repeats fused to
GFP was cloned in the inducible expression vector
pLVX TRE3G. To generate lentiviral particles
encoding the gene of interest, HEK293/T cells
were transfected with the expression vector and
Lenti-X Packaging mix (VSV-G). For all steps, cells
were grown under tetracycline-free conditions.
Lentiviral particles were collected 48 and 72 h
post-transfection, pooled and concentrated using
PEG precipitation. Lentiviral particles were resus-
pended in PBS and stored at −80 °C. For trans-
duction, SH-SY5Y cells were incubated with
lentiviral particles in DMEM supplemented with
5% FBS and 8 μg/ml polybrene. The following day,
the medium was exchanged with DMEM, 10% FBS
and 5%Pen/Strep. Aliquots of the generated stable
cell lines were frozen in liquid nitrogen for future
experiments.
Microarray analysis
The splicing sensitive human Clariom D assay
(Affymetrix, Thermo Fisher Scientific Inc.) was used
to analyze differential splicing events between control
and CAG 68 expressing SH-SY5Y cells. The human
ClariomD assay covers the whole transcribed genome
including all known splice variants (coding and non-
coding). The GeneChip WT PLUS Reagent Kit
(Affymetrix, Thermo Fisher Scientific Inc.) was used
to generate biotinylated sense-strand cDNA of the
whole transcriptome from 100 ng of total RNA from
three biological replicates. Array processing was
performed using the Affymetrix GeneChip Hybridiza-
tion, Wash and Stain kit. cDNA was hybridized to
human Clariom D arrays for 16h in a 45°C incubator
with 60-rpm rotation. After washing and staining using
the Fluidics Station 450, themicroarrays were scanned
with theAffymetrixGeneChipScanner 3000, according
to the manufacturer's instructions.
The data were analyzed with the Transcriptome
Analysis Console (TAC) 3.1 and Expression Console
1.4 software fromAffymetrix (Affymetrix, ThermoFisher
Scientific Inc.). Exons with ≥2-fold-change and
p b 0.05 were selected as being significantly differen-
tially expressed.
JTable 1. Clinical features of brain tissue donors
ID Sex Age CAG repeat PMD
C1 M 42 – 14
C2 M 41 – 16
C3 M 89 – 19
C4 M 48 – –
C5 F 78 – –
C6 F 89 – –
HD1 M 41 19/39 11
HD2 M 40 18/51 15
HD3 F 67 15/42 9
HD4 M 75 19/43 3
HD5 F 53 21/47 12
HD6 F 57 23/43 –
HD7 M 62 20/44 –
HD8 M 48 21/45 –
M, male; F, female; PMD, post-mortal delay.
1875RNA-Induced Toxicity in Huntington's DiseaseAnalysis of splice site strengths
We used the MaxEntScan algorithm [36] to
compare splice site strengths of retained to non-
retained introns.
siRNA transfection
SH-SY5Y cells were seeded in 24-well plates
(105 cell/well) 1 day prior to transfection. The PRPF8
siRNAs (GeneSolution Cat. No. 1027416, Gene ID:
10594; Qiagen) were pooled to a final concentration
of 20 μM. As a negative control, a non-silencing
siRNA (AATTCTCCGAACGTGTCACGT) was used.
siRNA cocktail (2.5 μl) per well was transfected
using Lipofectamine 2000 (Thermo Fisher Scientific)
according to the manufacturer's instructions.
Western blot
Protein extracts were dissolved in SDS-PAGE
sample buffer and boiled 10 min at 95 °C, separated
on SDS gels and blotted onto PVDF membranes
(Roche). For detection of specific proteins, the
following antibodies were used: anti-PRPF8 anti-
body (abcam, ab79237), anti-SON antibody (Sigma
HPA023535), anti-PSPC1 antibody (Abnova
PAB23359), anti-SNRNP40 antibody (Abnova
PAB21803) and anti-actin antibody (Cell signaling,
4967L).
Quantitative RT-PCR
Total RNA was isolated using the RNeasy Mini Kit
(Qiagen). cDNA was synthesized using the TaqMan
reverse transcription reagents kit (AppliedBiosystems),
and real-time PCR was carried out using the SYBR-
Green PCR master mix (Applied Biosystems). Sam-
ples were analyzed in quadruplicates. Data shown
represent mean ± SEM. Primers used were: GAPDH-
forward CCACCCATGGCAAATTCC GAPDH-reverse
TGGGATTTCCATTGATGACAAG CREB1-forward
CAATGGGCAGACAGTTCAAG CREB1-intron-
reverse GTTCTCTCCAAATCTAGGACC CREB1-
exon-reverse TTCGCTTTTGGGAATCAGTT. p
Values are the result of a factorial ANOVA determining
the knock-down or genotype effect, correcting for
CREB1 exon expression, and a confounding effect of
the qRT-PCR experiment.
Human postmortem brain samples
Human brain tissue was collected and stored as
previously described [37]. Tissue was obtained with
the families' full consent and with the approval of the
Leiden University Medical Center institutional Ethics
Committee. The experiments conformed to the
principles set out in the WMA Declaration of Helsinki
and the Department of Health and Human ServicesBelmont Report. Detailed information about patients
is given in Table 1.
Drosophila genetics
The GMR-Gal4 stock was kindly provided by
P. Meier (ICR, London); UAS-flag-Prp8 stock was a
gift from M. Uhlirova, University of Cologne, Germany
[38]; and UAS-HttEx1Q97 was obtained from Bloom-
ington stock center (No. 68417). Flies were raised on
standard fly medium and crossed at 25 °C. Progenies
were moved to 27 °C at day 3.
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